Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Rheumatology
•
Psoriatic arthritis
•
General Rheumatology
•
Dermatology
Would you continue TNF-inhibitor in a patient with psoriatic arthritis who has had multiple nonmelanoma skin cancers requiring Mohs surgery?
Related Questions
Can Dupixent (dupliumab) be safely used in patients who are taking other biologics for rheumatic disease?
How do you approach managing nausea and GI side effects when initiating methotrexate?
How would you approach management of a patient with longstanding history of SLE, but having active psoriasis?
Can Xolair (omalizumab) be safely used in combination with biologics for patients with rheumatic disease?
Are you comfortable with using NSAIDs in a patient on methotrexate for inflammatory arthritis?
What is your approach to treatment in patients with cutaneous mastocytosis and inflammatory arthritis?
How would you manage active psoriasis and psoriatic arthritis in patient on Rituximab and prednisone for MPO positive vasculitis?
How would you manage a patient with hidradenitis suppurativa and inflammatory arthritis (RA vs. PsA)?
Does your institution have formal policies or work flows to reduce unnecessary IGRAs ordered for patients on biologics?
What circumstances would drive you to consider using an oral IL-23 inhibitor over parenteral options for the management of psoriasis and/or psoriatic arthritis?
